Lung Health - the Future of Respiratory Health
Maintaining healthy lungs has become a priority and novel health concern. However, monitoring the lungs and respiratory health has not yet made into our daily self-care routines. The respiratory monitoring market is growing (8 to 10% CAGR, 2020-2025) (2), but is largely B2B.
At-home consumer devices could set the foundation for early detection, thereby encouraging habits that lessen the risk of pulmonary conditions.
Startups like NuvoAir and LungPass are paving the way in this market. NuvoAir currently provides at-home lung monitoring for asthma and cystic fibrosis, but the company plans to expand to COPD (chronic obstructive pulmonary disease), which degrades the airways in the lungs. Alarmingly, COPD is the third leading cause of death in the USA – but it can be prevented and treated (in some cases) if diagnosed early and managed well. As Lung Pass rightly put it: ‘Listen to your lungs’.